Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AIMT | AMGN | VRTX | REGN | BMY |
| Company | Aimmune Therap | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 34.56 | 300.12 | 413.33 | 969.90 | 44.00 |
| High | 34.56 | 301.79 | 422.17 | 971.86 | 44.22 |
| Low | 34.48 | 298.89 | 412.12 | 963.52 | 43.84 |
| Last | 34.49 | 301.44 | 422.98 | 966.67 | 43.92 |
| Change | -0.10 | +1.14 | +12.74 | -3.30 | -0.12 |
| % Change | -0.29% | +0.38% | +3.11% | -0.34% | -0.27% |
| Volume | 987,200 | 152,158 | 294,523 | 28,335 | 867,546 |
| 20-Day Average Volume | 1,628,530 | 2,732,937 | 1,061,459 | 504,173 | 13,841,394 |
| Previous Close | 34.59 | 300.30 | 410.24 | 969.97 | 44.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 34.37 | 276.96 | 399.71 | 913.75 | 46.40 |
| 20-Day Raw Stochastic | 70.59% | 63.63% | 98.09% | 95.51% | 7.35% |
| 20-Day Relative Strength | 83.15% | 62.87% | 60.20% | 61.19% | 29.43% |
| Weighted Alpha | -31.00 | +27.99 | +21.51 | +30.32 | -36.45 |
| Today's Opinion | 88% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Buy | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 24% Buy | 40% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 10/05/20 | +8.19% since 05/01/24 | +4.24% since 05/01/24 | +7.09% since 05/01/24 | -0.78% since 05/01/24 |
| Low | 34.42 on 10/07/20 | 274.90 on 05/02/24 | 394.03 on 05/07/24 | 891.30 on 05/02/24 | 43.33 on 05/02/24 |
| High | 34.59 on 10/09/20 | 322.60 on 05/03/24 | 419.76 on 05/08/24 | 971.86 on 05/08/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | +0.85% since 09/11/20 | +11.47% since 04/08/24 | +3.71% since 04/08/24 | +3.09% since 04/08/24 | -14.16% since 04/08/24 |
| Low | 34.21 on 09/14/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 34.59 on 10/09/20 | 322.60 on 05/03/24 | 419.76 on 05/08/24 | 971.86 on 05/08/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +119.96% since 07/10/20 | +1.77% since 02/08/24 | -0.91% since 02/08/24 | +2.23% since 02/08/24 | -9.95% since 02/08/24 |
| Low | 11.82 on 08/28/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 34.59 on 10/09/20 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +115.29% since 04/09/20 | +9.81% since 11/08/23 | +11.21% since 11/08/23 | +17.59% since 11/08/23 | -16.32% since 11/08/23 |
| Low | 11.82 on 08/28/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 34.59 on 10/09/20 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,257,370 | 161,091,424 | 106,030,224 | 106,465,840 | 89,273,480 |
| Shares Outstanding, K | 65,450 | 536,435 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -248,500,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -69,240,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.76 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.06 on 07/30/20 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/04/20 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 26.73 | 25.83 | 41.81 |